AIV Logo AIV Assistant

 Logo The Oncology Institute Inc. Common Stock - TOI 2.44 USD

EPS
-0.70
P/B
37.63
ROE
-277.62
Beta
0.16

2.440 USD

2.440 USD

Daily: +0.00%
Key Metrics

Earnings date: Aug. 11, 2025

EPS: -0.70

Book Value: 0.06

Price to Book: 37.63

Debt/Equity: 2020.06

% Insiders: 14.414%

Growth

Revenue Growth: 0.10%

Estimates

Forward P/E: -13.41

Forward EPS: -0.16

 Logo About The Oncology Institute Inc. Common Stock - (TOI)

Country: United States

Sector: Health Care

Website: nan

The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, counseling services, and 24/7 patient assistance services. The company also provides and manages clinical trials, palliative care programs, stem cell transplants services, other care delivery models associated with non-community-based academic, and tertiary care settings; and conducts clinical trials for a range of pharmaceutical, and medical device companies. It serves adult and senior cancer patients. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.

Exchange Ticker
NMS (United States) TOI

Dividends

Historical Split Corporate Actions

Trades
My Trades
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion